A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease.

A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease.

BACKGROUND:Cervical cancer is the most common female malignancy in the developing nations and the third most common cancer in women globally. An effective, inexpensive and self-applied topical treatment would be an ideal solution for treatment of screen-detected, pre-invasive cervical disease in low...

Full description

Bibliographic Details
Main Authors: Lynne Hampson, Innocent O Maranga, Millicent S Masinde, Anthony W Oliver, Gavin Batman, Xiaotong He, Minaxi Desai, Parmenas M Okemwa, Helen Stringfellow, Pierre Martin-Hirsch, Alex M Mwaniki, Peter Gichangi, Ian N Hampson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4732739?pdf=render

Internet

http://europepmc.org/articles/PMC4732739?pdf=render

Similar Items